E21 Category · further specificity required Hyperparathyroidism and other disorders of parathyroid gland
ICD-10-CM E21 identifies “Hyperparathyroidism and other disorders of parathyroid gland” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Excludes 14
Excludes 21
familial hypocalciuric hypercalcemia (E83.52)
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E20-E35 · Disorders of other endocrine glands (E20-E35)
More specific codes
E21.0Primary hyperparathyroidismBillable / specificE21.1Secondary hyperparathyroidism, not elsewhere classifiedBillable / specificE21.2Other hyperparathyroidismBillable / specificE21.3Hyperparathyroidism, unspecifiedBillable / specificE21.4Other specified disorders of parathyroid glandBillable / specificE21.5Disorder of parathyroid gland, unspecifiedBillable / specificOfficial index references
References from other codes (2)
Excludes 1 · parathyroid disorders (E20-E21)
Code first · hyperparathyroidism (E21.-)
History
Code history
Latest recorded change · FY2022
Effective from
- Code-level rules changed
Hyperparathyroidism and other disorders of parathyroid gland
Category — select a more specific code
CDC/NCHS · FY2022All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Code-level rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.